382 related articles for article (PubMed ID: 26790428)
1. QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.
King MT; Costa DS; Aaronson NK; Brazier JE; Cella DF; Fayers PM; Grimison P; Janda M; Kemmler G; Norman R; Pickard AS; Rowen D; Velikova G; Young TA; Viney R
Qual Life Res; 2016 Mar; 25(3):625-36. PubMed ID: 26790428
[TBL] [Abstract][Full Text] [Related]
2. German value sets for the EORTC QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30.
Kemmler G; Gamper E; Nerich V; Norman R; Viney R; Holzner B; King M;
Qual Life Res; 2019 Dec; 28(12):3197-3211. PubMed ID: 31485913
[TBL] [Abstract][Full Text] [Related]
3. Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30.
King MT; Viney R; Simon Pickard A; Rowen D; Aaronson NK; Brazier JE; Cella D; Costa DSJ; Fayers PM; Kemmler G; McTaggart-Cowen H; Mercieca-Bebber R; Peacock S; Street DJ; Young TA; Norman R;
Pharmacoeconomics; 2018 Feb; 36(2):225-238. PubMed ID: 29270835
[TBL] [Abstract][Full Text] [Related]
4. Japanese value set for the EORTC QLU-C10D: A multi-attribute utility instrument based on the EORTC QLQ-C30 cancer-specific quality-of-life questionnaire.
Shiroiwa T; King MT; Norman R; Müller F; Campbell R; Kemmler G; Murata T; Shimozuma K; Fukuda T
Qual Life Res; 2024 May; ():. PubMed ID: 38724771
[TBL] [Abstract][Full Text] [Related]
5. U.K. utility weights for the EORTC QLU-C10D.
Norman R; Mercieca-Bebber R; Rowen D; Brazier JE; Cella D; Pickard AS; Street DJ; Viney R; Revicki D; King MT;
Health Econ; 2019 Dec; 28(12):1385-1401. PubMed ID: 31482619
[TBL] [Abstract][Full Text] [Related]
6. United States Utility Algorithm for the EORTC QLU-C10D, a Multiattribute Utility Instrument Based on a Cancer-Specific Quality-of-Life Instrument.
Revicki DA; King MT; Viney R; Pickard AS; Mercieca-Bebber R; Shaw JW; Müller F; Norman R
Med Decis Making; 2021 May; 41(4):485-501. PubMed ID: 33813946
[TBL] [Abstract][Full Text] [Related]
7. French Value-Set of the QLU-C10D, a Cancer-Specific Utility Measure Derived from the QLQ-C30.
Nerich V; Gamper EM; Norman R; King M; Holzner B; Viney R; Kemmler G
Appl Health Econ Health Policy; 2021 Mar; 19(2):191-202. PubMed ID: 32537694
[TBL] [Abstract][Full Text] [Related]
8. Dutch utility weights for the EORTC cancer-specific utility instrument: the Dutch EORTC QLU-C10D.
Jansen F; Verdonck-de Leeuw IM; Gamper E; Norman R; Holzner B; King M; Kemmler G;
Qual Life Res; 2021 Jul; 30(7):2009-2019. PubMed ID: 33512653
[TBL] [Abstract][Full Text] [Related]
9. Deriving a preference-based utility measure for cancer patients from the European Organisation for the Research and Treatment of Cancer's Quality of Life Questionnaire C30: a confirmatory versus exploratory approach.
Costa DS; Aaronson NK; Fayers PM; Grimison PS; Janda M; Pallant JF; Rowen D; Velikova G; Viney R; Young TA; King MT
Patient Relat Outcome Meas; 2014; 5():119-29. PubMed ID: 25395875
[TBL] [Abstract][Full Text] [Related]
10. The EORTC QLU-C10D: The Canadian Valuation Study and Algorithm to Derive Cancer-Specific Utilities From the EORTC QLQ-C30.
McTaggart-Cowan H; King MT; Norman R; Costa DSJ; Pickard AS; Regier DA; Viney R; Peacock SJ
MDM Policy Pract; 2019; 4(1):2381468319842532. PubMed ID: 31245606
[No Abstract] [Full Text] [Related]
11. Assessing health-related quality of life in cancer survivors: factors impacting on EORTC QLU-C10D-derived utility values.
van Gelder T; Mulhern B; Schoormans D; Husson O; De Abreu Lourenço R
Qual Life Res; 2020 Jun; 29(6):1483-1494. PubMed ID: 31938965
[TBL] [Abstract][Full Text] [Related]
12. Development of computerised adaptive testing (CAT) for the EORTC QLQ-C30 dimensions - general approach and initial results for physical functioning.
Petersen MA; Groenvold M; Aaronson NK; Chie WC; Conroy T; Costantini A; Fayers P; Helbostad J; Holzner B; Kaasa S; Singer S; Velikova G; Young T;
Eur J Cancer; 2010 May; 46(8):1352-8. PubMed ID: 20231085
[TBL] [Abstract][Full Text] [Related]
13. EORTC QLU-C10D value sets for Austria, Italy, and Poland.
Gamper EM; King MT; Norman R; Efficace F; Cottone F; Holzner B; Kemmler G;
Qual Life Res; 2020 Sep; 29(9):2485-2495. PubMed ID: 32458409
[TBL] [Abstract][Full Text] [Related]
14. Danish value sets for the EORTC QLU-C10D utility instrument.
Lehmann J; Rojas-Concha L; Petersen MA; Holzner B; Norman R; King MT; Kemmler G;
Qual Life Res; 2024 Mar; 33(3):831-841. PubMed ID: 38183563
[TBL] [Abstract][Full Text] [Related]
15. Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy.
Bulamu NB; Vissapragada R; Chen G; Ratcliffe J; Mudge LA; Smithers BM; Isenring EA; Smith L; Jamieson GG; Watson DI;
Health Qual Life Outcomes; 2021 Oct; 19(1):233. PubMed ID: 34600554
[TBL] [Abstract][Full Text] [Related]
16. The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors.
Knobel H; Loge JH; Brenne E; Fayers P; Hjermstad MJ; Kaasa S
Palliat Med; 2003 Dec; 17(8):664-72. PubMed ID: 14694917
[TBL] [Abstract][Full Text] [Related]
17. Deriving a Preference-Based Measure for Myelofibrosis from the EORTC QLQ-C30 and the MF-SAF.
Mukuria C; Rowen D; Brazier JE; Young TA; Nafees B
Value Health; 2015 Sep; 18(6):846-55. PubMed ID: 26409613
[TBL] [Abstract][Full Text] [Related]
18. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
19. Deriving a preference-based measure for cancer using the EORTC QLQ-C30.
Rowen D; Brazier J; Young T; Gaugris S; Craig BM; King MT; Velikova G
Value Health; 2011; 14(5):721-31. PubMed ID: 21839411
[TBL] [Abstract][Full Text] [Related]
20. Thresholds for clinical importance for four key domains of the EORTC QLQ-C30: physical functioning, emotional functioning, fatigue and pain.
Giesinger JM; Kuijpers W; Young T; Tomaszewski KA; Friend E; Zabernigg A; Holzner B; Aaronson NK
Health Qual Life Outcomes; 2016 Jun; 14():87. PubMed ID: 27267486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
